Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

PCOS is a hormonal disorder in women that can cause infertility and increases the risk of heart and metabolic issues.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Women with irregular periods have a higher risk of heart disease.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Prediabetes may be a risk factor for hair loss.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Men with male pattern baldness may have a higher risk of heart problems.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Healthy lifestyle changes, especially weight loss, can improve symptoms and overall health in people with Polycystic Ovary Syndrome, especially if they are overweight or obese.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.